Show simple item record

dc.contributor.authorBorracci, Raul.
dc.contributor.authorAmrein, Eugenia.
dc.contributor.authorAlvarez, José.
dc.contributor.authorEt al.
dc.date.accessioned2023-10-17T16:04:51Z
dc.date.available2023-10-17T16:04:51Z
dc.date.issued2021-08
dc.identifier.citationActa Cardiol . 2021 Aug;76(6):623-631.es
dc.identifier.issn0373-7934
dc.identifier.urihttps://riu.austral.edu.ar/handle/123456789/2326
dc.descriptionDisponible en: https://pubmed.ncbi.nlm.nih.gov/32619160/es
dc.description.abstractAbstract Background: All previous meta-analyses including clinical outcomes after remote ischaemic conditioning (RIC) in patients with ST-elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) demonstrated that RIC significantly reduced all-cause mortality and major adverse cardiovascular events (MACE). Following the publication of these meta-analyses, three new randomised controlled clinical trials (RCT) including 5712 patients were reported. The objective of this study was to perform an updated meta-analysis about the effectiveness of RIC in reducing MACE in patients with STEMI undergoing PCI. Methods: The search strategy included only RCT identified in MEDLINE, Embase, SCOPUS, and Cochrane (up to February 2020). Eligible studies included any type of RIC. The study adhered to the Preferred Reporting Items of Systematic Reviews and Meta-Analysis (PRISMA) statement. The studies quality was evaluated with Cochrane Risk of Bias tool and Jadad score. Results: Twelve RCT were included in the analysis (Q = 18.8, p = 0.065, I2 = 41.5%, 95%CI 0.0-70.3). Globally, 8239 STEMI patients with 816 MACE were reported with follow-ups between 1 and 45 months. Random effects model showed no significant effect of RIC on composite clinical endpoints (OR = 0.77, 95%CI 0.59-1.01, p = 0.105). Sensitivity analysis demonstrated that only the exclusion of CONDI-2/ERIC PPCI trial modified the significance of the global effect (OR 0.66, 95%CI 0.47-0.93), favouring RIC intervention. Conclusions: The current updated meta-analysis showed that use of RIC around the time of PCI for STEMI treatment added no significant benefit for clinical outcomes assessed between 6 and 45 months after the procedure. These conclusions are in direct contrast to previously published meta-analyses. Keywords: Ischaemic conditioning; meta-analysis; myocardial infarction; percutaneous coronary intervention; remote ischaemic conditioning.es
dc.language.isoenes
dc.publisherTaylor and Francis Groupes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectIschaemic conditioninges
dc.subjectMeta-analysises
dc.subjectMyocardial infarctiones
dc.titleRemote ischaemic conditioning in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention: an updated meta-analysis of clinical outcomeses
dc.typeArticlees


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional